Talk:Main Page: Difference between revisions

From Umbrary
Jump to navigation Jump to search
No edit summary
No edit summary
Line 135: Line 135:
<div style="border:1px solid black; padding: 5px; border-color: #DDDDDD; margin-top: 15px; margin-bottom: 15px; margin-right: 15px; margin-left: 15px;">
<div style="border:1px solid black; padding: 5px; border-color: #DDDDDD; margin-top: 15px; margin-bottom: 15px; margin-right: 15px; margin-left: 15px;">


<blockquote><span style="font-size:medium">'''[[Category:Featured|Featured article]]'''</span>
<blockquote><span style="font-size:medium">'''[[Category:Featured | Featured article]]'''</span>


<choose>
<choose>

Revision as of 05:30, 24 September 2022


About Us
People-icon.svg

This wiki contains everything a budding mad (gender) scientist needs to further their work! Specifically, the driving goals behind this wiki are to:

  • Educate ourselves about the biology underlying transition and developmental sex differentiation.
  • Postulate and collect a compendium of hypothetical treatments that warrant further research.
  • Reduce harm by bringing together official standards of care for gender identities and intersex conditions.
  • Enable access to needed information freely to those who require help navigating the systems.
  • Provide a forum for people whom these conditions affect the most to become more educated and involved in the processes of their treatments, advancing healthcare ourselves!


Contact Us
Envelope.svg

The collection of libraries and lists on this website is curated by Umbra who can be contacted at umbrary@gmail.com.

You can request her services as a research librarian through the form found on the research requests page.




Recent Changes
Newspaper-icon.svg

No changes during the given period match these criteria.


Research Updates
Logo simple2.svg

Featured research

Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy.

A comparison between the ability of cyproterone acetate and spironolactone to lower testosterone levels. Although it shows that cyproterone has a greater effect towards lowering testosterone levels, it ironically notes this metric isn't very meaningful since spironolactone is only an antagonist and does not inhibit steroidogenesis.

The Papers page is a thorough compendium of up-to-date trans-specific research with a high quality of evidence, as well as guides on ways to access them, or find more research.

It is at the heart of all our goals stated in the "About Us" tab below, and one of the more polished articles on the wiki having been curated by our research librarian LilianaUmbra.


Featured Articles
Portal 2.svg

'

Papers